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I. INTRODUCTION 
At 10:27 a.m. the Warden held a microphone up to Dennis McGuire and asked for 
his last words.1  Dennis McGuire mouthed, “I love you” and “I will see you on the 
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 1 Trial Pleading at ¶ 54, In re Dennis R. McGuire v. Mohr, No. 2:14-CV-00093 (S.D. Ohio 
filed Jan. 24, 2014), 2014 WL 309071.  
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other side” to his wife and daughter sitting in the observation room, minutes before he 
was to be executed.2  What normally takes eight minutes,3 took two and a half times 
as long4—a full 20 minutes, as Mr. McGuire began writhing in pain, pushing and 
arching his back while simultaneously pushing against the gurney.5  He was able to 
get his back and neck off the gurney three to four inches, even though he was strapped 
down at the waist, feet and hands.6  During the twenty-minute execution, members of 
the execution team had horrified looks on their faces with both wide eyes and shocked 
expressions.7  At 10:53 a.m., the Warden pronounced Mr. McGuire dead and another 
member of the execution team, who had seen the botched execution unfold mouthed 
“I'm sorry” to Mr. McGuire’s family in the observation room.8 
Ohio’s statute for carrying out the death sentence9 lacks a critical piece of 
information—where to purchase drugs used in lethal injections.  Before the supply ran 
out, Ohio used the drug pentobarbital,10 but switched to a two-drug combination of 
midazolam and hydromorphone11 for the execution of Mr. McGuire.  Previous 
                                                          
 2 Id.  
 3 See Peter Sergo, How Does Lethal Injection Work, SCIENCELINE (Nov. 12, 2007), 
http://scienceline.org/2007/11/ask-sergo-deathpenalty (“According to a 2002 study in the 
Journal of Forensic Science, the average length of time from the first injection to death is 8.4 
minutes”). 
 4 See Sergo, supra note 3; see also In re Dennis R. McGuire, supra note 1 at ¶¶ 56, 66.   
 5 See In re Dennis R. McGuire, supra note 2 at ¶ 55-60, 66. 
 6 Id. 
 7 Id. at ¶ 62.  
 8 Id. at ¶ 67.  
 9 See Ohio Rev. Code Ann. § 2949.22 (West, Westlaw through Files 1 to 140 and 
Statewide Issue 1 of the 130th GA (2013-2014))  
“(A) Except as provided in division (C) of this section, a death sentence 
shall be executed by causing the application to the person, upon whom the 
sentence was imposed, of a lethal injection of a drug or combination of 
drugs of sufficient dosage to quickly and painlessly cause death. The 
application of the drug or combination of drugs shall be continued until the 
person is dead. The warden of the correctional institution in which the 
sentence is to be executed or another person selected by the director of 
rehabilitation and correction shall ensure that the death sentence is 
executed.” 
 10 State by State Lethal Injection, DEATH PENALTY INFORMATION CENTER, 
http://www.deathpenaltyinfo.org/state-lethal-injection (referring to Ohio in chart).  
 11 See id; see also WOLTERS KLUWER, LIPPINCOT, WILLIAMS & WILKINS, NURSING 2011 
DRUG HANDBOOK 755-56, 778-79 (2011) (Hydromorphone can cause respiratory depression in 
which the patient should be monitored constantly. See id. at 755. It is advised that resuscitation 
equipment should be available. Id. Overdose of hydromorphone can cause “constricted pupils, 
cold clammy skin . . . respiratory depression . . . cardiac arrest [and] death.” Id. at 756. 
Midazolam is used to “induce sleepiness and amnesia and to relieve apprehension before 
anesthesia or before or during procedures.” Id. at 778); see also Alan Johnson, Ohio Revises 
Death Penalty Protocol, Will Delay Executions, COLUMBUS DISPATCH (Jan. 9, 2015) 
http://www.dispatch.com/content/stories/local/2015/01/08/death-penalty-protocol.html 
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suppliers from overseas are refusing to sell these drugs to prisons, including prisons 
in Ohio.12  As a result, the Ohio Department of Rehabilitation and Corrections 
(“ODRC”) has turned to compounding pharmacies13 for a new source of drugs.14  
However, compounding pharmacies are highly problematic . . . because they are non-
FDA regulated which means that regulation is left to the states.15  Essentially, 
compounding pharmacies “tend to differ from one state to the next, making it difficult 
to ensure that compounded drugs are held to consistently high standards of quality, 
safety and effectiveness.”16 
Ohio’s statute is similar to the death sentence statute in Oklahoma,17 as both states 
statutes are silent on where to obtain drugs used in lethal injections.  Notably, both 
states have experienced recent botched executions.18  In response, Judge Frost from 
the Southern District of Ohio ordered a stay of all executions in the state until January 
15, 2015.19  The first execution under Ohio’s newly adopted execution protocol20 is 
scheduled for January 21, 2016.21  This note argues that the ODRC should not obtain 
lethal injection drugs from unregulated compounding pharmacies. Ohio should only 
                                                          
(Recently, the ODRC amended their drug cocktail again: “Ohio will add thiopental sodium, a 
drug used previously, and drop the two-drug regimen of midazolam and hydromorphone, which 
caused problems in the last execution a year ago. But until the Ohio Department of 
Rehabilitation and Correction can get supplies of pentobarbital, a drug already permitted, or 
thiopental sodium, executions will be postponed”) (emphasis added).  
 12 See Alan Johnson, Judge Orders Temporary Moratorium on Ohio Executions, 
COLUMBUS DISPATCH (May 29, 2014) http://www.dispatch.com/content/stories/local/
2014/05/28/temporary-moratorium-on-lethal-injections.html.  
 13 See Deborah W. Denno, Lethal Injection Chaos Post-Baze, 102 GEO. L.J. 1331, 1332 
(2014) (“[C]ompounding pharmacies are non-FDA regulated, small scale pharmacies that make 
customized drugs on an as-needed basis in response to individual prescriptions”). 
 14 Johnson, supra note 12.  
 15 Denno, supra note 13, at 1331.  
 16 Id. 1332 
 17 See 22 OKL. ST. ANN. § 1014 (West 2015).  
 18 See generally Michael L. Radelet, Examples of Post-Furman Botched Executions, DEATH 
PENALTY INFORMATION CENTER, http://www.deathpenaltyinfo.org/some-examples-post-
furman-botched-executions?scid=8&did=478 (last updated July 24, 2014).  
 19 See Order, In Re Ohio Execution Protocol Litigation, No. 2:11-cv-01016 (S.D. Ohio Aug. 
18, 2014), ECF No. 492; see also Order, In Re Ohio Execution Protocol Litigation, No. 2:11-
cv-01016 (S.D. Ohio Dec. 23, 2014), ECF No. 503. 
 20 See ODRC OHIO EXECUTION PROTOCOL, 
http://drc.ohio.gov/web/drc_policies/documents/01-COM-11.pdf (last updated Jan. 9, 2015) 
(“If a sufficient quantity of pentobarbital or thiopental sodium is available, then the scheduled 
execution shall proceed with intravenous administration of either pentobarbital or thiopental 
sodium, as determined by the Warden, in accordance with the terms of this policy. If a 
sufficient quantity of pentobarbital or thiopental sodium is not available, or if at any time the 
available pentobarbital or thiopental sodium is deemed unusable by the Medical Team, then 
the Warden shall consult with the Director and they shall notify the Governor”).  
 21 See Execution Schedule, OHIO DEP’T OF REHABILITATION AND CORRECTION, http://
www.drc.ohio.gov/Public/executionschedule.htm (last updated Jan. 30, 2015).  
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purchase drugs from an FDA-registered outsourcing facility. Part II explores the death 
sentence statute in Ohio and the use of compounding pharmacies.  Part III compares 
Oklahoma’s statute in conjunction with Ohio and illustrates the adverse effects by 
utilizing compounding pharmacies. Part IV proposes recommendations to Ohio’s 
execution protocol.  Part V provides a conclusion. 
II. BACKGROUND 
Ohio’s implementation of the death sentence statute22 is minimal in prescribing the 
precise manner for carrying out the lethal injection protocol.  Instead, Ohio’s execution 
protocol, designed and written by the Warden himself, designates the Warden to be in 
charge, with the assistance of medical personnel, for carrying out all death sentences.23  
Currently, the execution statute simply requires that the: 
[D]eath sentence shall be executed by causing the application to the person, 
upon whom the sentence was imposed, of a lethal injection of a drug or 
combination of drugs of sufficient dosage to quickly and painlessly cause 
death. The application of the drug or combination of drugs shall be 
continued until the person is dead.24  
The statute is silent on where to purchase these drugs, which has afforded the 
ODRC, specifically the Warden, enormous freedom in purchasing these life-ending 
drugs.25  As a result, Ohio has suffered negative consequences from utilizing 
compounding pharmacies to purchase these drugs, which were brought to the public 
light by the unfortunate botched execution of Dennis McGuire.26 
                                                          
 22 See OHIO REV. CODE ANN. § 2949.22 (West 2015). 
 23 See Ohio Execution Protocol, supra note 20 (“The Warden of that facility, or Deputy 
Warden in the absence of the Warden, is responsible for carrying out the death sentence on the 
date established by the Ohio Supreme Court. At least three Medical Team Members, two of 
whom are authorized to administer drugs under Ohio law, shall be used in the conduct of court-
ordered executions. Functions required to be performed by medically-qualified persons, as 
described in this policy, shall be performed by Medical Team Members”).  
 24 Id.  
 25 See e.g., Alan Johnson, Ohio Can Use Compounding Pharmacies for Execution Drugs, 
COLUMBUS DISPATCH (Oct. 5, 2013), http://www.dispatch.com/content/stories/local/
2013/10/04/new-drugs-added-to-Ohio-execution-policy.html; see also OHIO REV. CODE ANN. 
§ 2949.22 (West 2015) (“The Warden controls most aspects of the death sentence: “A death 
sentence shall be executed within the walls of the state correctional institution designated by 
the director of rehabilitation and correction as the location for executions, within an enclosure 
to be prepared for that purpose, under the direction of the warden of the institution or, in the 
warden's absence, a deputy warden, and on the day designated by the judge passing sentence 
or otherwise designated by a court in the course of any appellate or post-conviction 
proceedings.”) (emphasis added).  
 26 See e.g., Gary Strauss, Ohio Killer's Slow Execution Raises Controversy, USA TODAY 
(Jan. 16, 2014), http://www.usatoday.com/story/news/nation/2014/01/16/ohio-killer-executed-
with-new-lethal-drug-combo/4512651/. 
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A. Ohio’s Death Sentence Statute: A Historical Approach 
Ohio has employed three different methods of capital punishment: public 
hangings, electrocution, and the current method of lethal injection.27  When Ohio was 
first recognized as a state in 1803, executions were performed by public hangings, 
before Ohio switched to the electric chair.28  In 1993, inmates on death row could 
choose between the electric chair and lethal injection.29  A few years later in 2001, 
Ohio Governor Bob Taft signed a bill that eliminated the electric chair completely, 
leaving lethal injection as the only option.30   
Before a death sentence is imposed on a defendant, there are numerous steps 
throughout the judicial process that must be satisfied.  First and foremost, Ohio courts 
that seek the death penalty, or a life sentence, must comply with the Ohio Revised 
Code (“ORC”) section 2929.04,31 which specifies a number of aggravating and 
mitigating factors to be evaluated by either a trial judge, jury, or three judge panel.32  
To date, Ohio has executed 393 convicted murderers by a combination of the three 
methods.33 
1. A Glimpse into Ohio’s Death Penalty Process 
In Ohio, in order for the prosecutor to seek the death penalty, certain aggravating 
factors must be specified on the indictment and proven beyond a reasonable doubt.34  
For example, one aggravating factor purports that:  
                                                          
 27 See generally Capital Punishment in Ohio, OHIO DEPARTMENT OF REHABILITATION AND 
CORRECTION, http://www.drc.ohio.gov/public/capital.htm (last updated Sept. 14, 2014) (“On 
November 15, 2001, Governor Bob Taft signed House Bill 362 eliminating the electric chair as 
a form of execution.” Id. “The only method of execution in Ohio is lethal injection.” Id. “On 
February 26, 2002, Ohio’s electric chair, nicknamed "Old Sparky," was decommissioned and 
disconnected from service.” Id. “The original electric chair was donated to the Ohio Historical 
Society on December 18, 2002, and a replica electric chair was donated to the Mansfield 
Reformatory Preservation Society.” Id.) 
 28 Id. (“Capital punishment has been a part of Ohio’s justice system since early in the state’s 
history. From 1803, when Ohio became a state, until 1885, executions were carried out by public 
hanging in the county where the crime was committed. In 1885, the legislature enacted a law 
that required executions to be carried out at the Ohio Penitentiary in Columbus.”).  
 29 Id. (“In 1993, a bill granting prisoners the option to choose between death by electrocution 
or lethal injection was passed and signed into law by former Governor George V. Voinovich. 
The Death Row inmate would be asked to choose between the two methods seven days before 
the scheduled execution. The law stipulated that if the prisoner did not choose, the default 
method of execution would be death by electrocution.”).  
 30 Id. (“On November 15, 2001, Governor Bob Taft signed House Bill 362 eliminating the 
electric chair as a form of execution. The only method of execution in Ohio is lethal injection.”).  
 31 See OHIO REV. CODE ANN. § 2929.04 (West 2015).  
 32 See OHIO REV. CODE ANN. § 2929.03(C)(1)(2)(a)(iii)(b)(i)(West, 2014)); see also OHIO 
REV. CODE ANN. § 2929.03(C)(1)(2)(a)(iii)(b)(ii) (West 2105).  
 33 See Capital Punishment in Ohio, supra note 27. 
 34 See generally OHIO REV. CODE ANN. § 2929.04(A) (West 2014) (Some aggravating 
factors include but are not limited to: the assassination of the President of the United States, or 
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The offense was committed while the offender was committing, attempting 
to commit, or fleeing immediately after committing or attempting to 
commit kidnapping, rape, aggravated arson, aggravated robbery, or 
aggravated burglary, and either the offender was the principal offender in 
the commission of the aggravated murder or, if not the principal offender, 
committed the aggravated murder with prior calculation and design.35 
In addition to weighing the aggravating factors, the trier of fact must also consider 
numerous mitigating factors, which include the “nature and circumstances of the 
offense, history, character, and background of the offender.”36  The trier of fact must 
also evaluate whether the offender was under duress or provocation, and consider the 
lack of an offender’s prior criminal history.37  Lastly, the trier of fact must decide 
whether the aggravating factors outweigh the mitigating factors in issuing a death or 
life sentence.  
There are currently 393 men and one woman sitting on death row in Ohio.38  In 
order for a criminal defendant to be subject to capital punishment there are three main 
requirements: he or she must be at least 18 years old when the offense was committed, 
the indictment must charge the defendant with aggravated murder plus an aggravating 
circumstance specification,39 and he or she must not be mentally retarded.40  In capital 
                                                          
person in line for succession of the presidency, the offense was committed for hire or purpose 
of escaping detection or trial, the victim was a law enforcement officer.) Id. 
 35 Id.  
 36 Id. 
 37 See id.  
 38 See Death Row Inmates, OHIO DEPARTMENT OF REHABILITATION AND CORRECTION, 
http://www.drc.ohio.gov/public/deathrow.htm (last updated Dec. 4, 2014).  
 39 See supra note 34; see also infra note 36, at 5-6 (“The following are Aggravating 
Circumstances in Ohio: 1. Assassination of President, Vice President, Governor or Lieutenant 
Governor; 2. Committed for hire; Committed for the purpose of escaping detection, 
apprehension, trial or punishment of another crime; 4. While in detention or at large from 
breaking detention; 5. Prior to the current offense, the offender was convicted of a purposeful 
killing or attempt to kill, or the offense was part of a course of conduct involving the purposeful 
killing or attempt to kill two or more persons; 6. The victim was a law enforcement officer, 
whom the offender knew or had reasonable cause to know was a law enforcement officer. The 
law enforcement officer was either engaged in work duties or the offender’s specific purpose 
was to kill a law enforcement officer; 7. The offense was committed, while the offender was 
committing, attempting to commit, or fleeing after committing or attempting to commit, 
kidnapping, rape, aggravated arson, aggravated robbery, or aggravated burglary and the 
offender was the principal offender in the aggravated murder, or if not the principal offender, 
the aggravated murder was committed by prior calculation and design; 8. Killing of a potential 
witness in a criminal case to prevent their testimony; 9. Killing of a person less than 13 years of 
age with prior calculation or design; or 10. The offense was committed while the offender was 
committing, attempting to commit, or fleeing immediately after committing, or attempting to 
commit terrorism”).  
 40 See Capital Crimes Annual Report, OHIO ATTORNEY GENERAL’S OFFICE (Apr. 1, 2014), 
http://www.ohioattorneygeneral.gov/getattachment/f8e455c3-b5b1-4ab5-bc24-4af0ffe41273/
2013-Capital-Crimes-Annual-Report.aspx (Aggravated murder is defined in ORC § 2903.01 
and the aggravating circumstances are defined in ORC § 2929.04(A)(1) – (A)(10)). Id. at 4-6. 
Furthermore, “Whenever an indictment charges the defendant with capital murder, the clerk of 
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punishment cases, trials are split into two phases—“the guilty phase and the 
sentencing or mitigation phase.”41  A criminal defendant has a right to a trial by jury 
during both phases of the trial.42  However, the defendant has an option to waive his 
right to a jury trial such that a three-judge panel will decide whether the defendant is 
guilty and impose a sentence.43  Before a criminal defendant can be sentenced, the 
prosecutor must prove beyond a reasonable doubt the defendant committed aggravated 
murder, in conjunction with an aggravating circumstance.44  Furthermore, the 
aggravating circumstance(s) must outweigh any mitigating circumstances.45 
A criminal defendant also has the option to file a petition for a writ a habeas 
corpus.46  A writ of habeas corpus orders the custodian of an individual in custody to 
produce the individual before a court either to inquire about the individual’s detention, 
to testify, or to appear for prosecution.47  Typically, an inmate files a petition for a writ 
of habeas corpus to contest: the way the sentence is being carried out, if that person is 
in custody because of something other than a judgment of conviction, or the person is 
alleging they are being illegally detained in immigration custody.48 
Once a criminal defendant exhausts all possible appeals,49 the defendant typically 
sits on death row for several years,50 before he or she is put to death. The Warden is 
responsible for carrying out the death sentence and must abide to the procedures 
prescribed in the Ohio execution protocol in addition to any statutory requirements.51  
A medical team of three people assists the Warden and at least two members must be 
authorized to administer drugs under Ohio law.52  All executions in Ohio take place at 
the Southern Ohio Correctional Facility, located in Lucasville, Ohio.53 
                                                          
the court in which the indictment is filed must provide notification to the Ohio Supreme Court. 
Notice must be filed within 15 days of the filing of the indictment and shall contain the following 
information: the name of the person; the docket number; the name of the court in which the case 
will be heard, and the date the indictment was filed.” Id. at 6.; see also State v. Lott, 97 Ohio 
St.3d 303 (2002) (establishing Ohio’s procedure for determining mental retardation).  
 41 Id. at 6. 
 42 Id. 
 43 Id. 
 44 Id. at 7. 
 45 Id. 
 46 See U.S. Const. art I, § 9, cl. 2; see also Petition for a Writ of Habeas Corpus Form, U.S. 
COURTS, available at http://www.uscourts.gov/uscourts/FormsAndFees/Forms/AO242.pdf.  
 47 See Service of Process, Writ of Habeas Corpus, U.S. MARSHALS SERVICE, http://www.
usmarshals.gov/process/habeas.htm (last visited Mar. 15, 2015).  
 48 See Petition for a Writ of Habeas Corpus Form, supra note 46. 
 49 See Capital Crimes Annual Report, supra note 40, at 8. 
 50 Id. at 24 (“The average numbers of years on death row in Ohio is 15.68 years”).  
 51 See OHIO EXECUTION PROTOCOL, supra note 20. 
 52 Id. at 3.  
 53 Id. at 4. 
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2. Dennis McGuire: Ohio’s Most Recent Execution 
Dennis McGuire experienced horrific complications during his execution in 
January 2014.54  Keeping in mind the end result of this execution, it is critical to 
understand Mr. McGuire’s case, and how he ended up on death row.  Mr. McGuire 
was indicted on December 22, 1993, and was sentenced to death on December 23, 
1994.55 After numerous unsuccessful appeals, Mr. McGuire was the “[o]nly person in 
Ohio to have been put to death using the combination of midazolam and 
hydromorphone.”56 
In the case of Dennis McGuire, the victim, Joy Stewart, approached Mr. McGuire 
because she wanted to purchase marijuana from him.57  The following day, Joy’s body 
was found in the woods.58  This homicide was investigated by the Preble County 
Prosecutor’s Office, but to no immediate avail.59  However, Mr. McGuire, while 
incarcerated on an unrelated offense, informed law enforcement that he had inside 
knowledge pertaining to Joy’s death.60  Mr. McGuire explained that his brother-in-
law, Jerry Richardson, forced Joy to have sex with him and that he “[s]tabbed her ‘in 
the shoulder bone’ and ‘cut her throat’.”61  The autopsy report revealed that Joy had 
been stabbed twice and the coroner had found an abundant amount of sperm.62  
However, while in prison, Mr. McGuire spoke to different people about Joy’s murder, 
implicating himself by stating he was going to blame it all on his brother-in-law, Jerry 
Richardson.63  After DNA and blood testing of Mr. McGuire, his brother-in-law Jerry 
Richardson, and the victim, “McGuire was indicted on one count of aggravated 
murder, with one felony-murder specification for rape.”64  Mr. McGuire was also 
indicted on two counts of rape (vaginal and anal) and one count of kidnapping.65  The 
indictment included a death penalty specification, which alleged that McGuire was the 
principal offender in an aggravated murder, which occurred while he was committing, 
                                                          
 54 See Johnson, supra note 11 (“During his Jan. 16, 2014, execution, McGuire choked and 
coughed for about 20 minutes before succumbing to the drug mixture. His son and daughter, 
who witnessed the execution, sued the state, alleging his death was cruel and unusual 
punishment.”).  
 55 See Capital Crimes Annual Report, supra note 40 at *235.  
 56 See Johnson, supra note 11. 
 57 See State v. McGuire, 686 N.E.2d 1112, 1115 (Ohio 1997).  
 58 Id.  
 59 Id.  
 60 Id. 
 61 Id.; see also id. (After describing in explicit detail how his brother-in-law, Jerry 
Richardson, murdered the Ms. Stewart, McGuire led investigators to a hayloft in a barn where 
the murder weapon, a knife was stored). 
 62 Id. 
 63 Id. at 1116. 
 64 Id. 
 65 Id.  
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attempting to commit, or fleeing immediately after committing a rape.66  Mr. McGuire 
pleaded not guilty to all counts,67 but the jury returned a verdict of guilty including the 
death sentence specification, which the trial judge imposed.68  The Ohio Court of 
Appeals for Preble County affirmed the death sentence of Mr. McGuire.69 
On appeal, the Supreme Court of Ohio affirmed Mr. McGuire’s convictions and 
the death sentence.70  The Supreme Court reasoned that McGuire’s statements tended 
to show guilt,71 which combined with the DNA evidence, was consistent with 
McGuire’s guilt.72  The Supreme Court reasoned that the mitigating factors of his 
turbulent childhood, lack of education, mental abuse and marijuana use did not 
outweigh the aggravating factors that he was the principal offender who “committed 
rape in conjunction with murder.”73 
B. A Rocky Road with Lethal Injection 
 “People who are detained or imprisoned do not cease to be human beings, no 
matter how serious the crime of which they have been accused or convicted.”74  “The 
court . . . which dealt with their case decreed that they should be deprived of their 
liberty, not that they should forfeit their humanity.”75  Our society adheres to a series 
of procedures to protect the individual—from the time a person is arrested76 through a 
person’s last appeal to the high court.77  The design of our judicial system in 
conjunction with the Eighth Amendment prohibition of cruel and unusual 
punishment78 illustrates why every person, no matter the crime committed, should be 
treated with dignity and entitled to humane treatment.  The safeguards should continue 
until a person, specifically on death row, takes their last breath.  We as a society should 
treat all persons on death row with respect—physical and mentally, which includes 
the actual execution process. Therefore, before the execution process even begins, 
                                                          
 66 State v. McGuire, No. CA95-01-001, 1996 WL 174609, at *1 (Ohio Ct. App. Apr. 15, 
1996); see infra text accompanying notes 31.  
 67 See McGuire, 1996 WL 174609, at *1. 
 68 See Id. 
 69 Id.  
 70 Id. at 1124.  
 71 Id. at 1118. 
 72 Id.  
 73 Id. at 1123. 
 74 See Andrew Coyle, A Human Rights Approach to Prison Management 31 (2009), 
available at http://www.prisonstudies.org/sites/prisonstudies.org/files/resources/
downloads/handbook_2nd_ed_eng_8.pdf. 
 75 Id.  
 76 See generally Miranda v. Arizona, 384 U.S. 436 (1966).   
 77 See The Appeals Process, UNITED STATES COURTS, http://www.uscourts.gov/
FederalCourts/UnderstandingtheFederalCourts/HowCourtsWork/TheAppealsProcess.aspx 
(last visited Mar. 15, 2015).  
 78 See U.S. CONST. amend. VIII.  
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Ohio should be very cautious of where the lethal injection drugs are purchased.  The 
ODRC should only purchase drugs for lethal injection from FDA-regulated 
outsourcing facilities to decrease the likelihood of another botched execution.  
1. Ohio: One Too Many People Have Suffered as a Result of Ohio’s Lethal Injection 
Procedures 
Ohio is no stranger to mishaps occurring with its lethal injection procedures.79  In 
addition to Dennis McGuire, Ohio has also botched three other executions: Joseph 
Clark, Christopher Newton, and Romell Broom.80   
The ODRC continues to amend the execution protocol, namely in the drugs 
utilized.81  In previous years, the ODRC repeatedly experienced execution 
complications by failing to adequately locate a suitable vein to commence the 
executions.82  After the execution of Mr. McGuire, it seems as if those troubles have 
been swept under the rug by the ODRC.  Presently, the main source of controversy 
focuses on where the drugs are purchased.  After the execution of Mr. McGuire, the 
ODRC should note that the seller of these drugs might be the root of the resulting 
complications.  
Joseph Clark was sentenced to death on November 28, 1984,83 but the 2006 
execution was not seamless.  The execution team took 22 minutes to find a suitable 
vein for the IV-injection of drugs.84  The overall execution took almost 90 minutes to 
complete,85 when the average time from injection of drugs until death lingers around 
eight minutes.86  Mr. Clark was able to lift himself off the gurney while stating; “it’s 
not working,” during the execution.87  A year later in 2007, the ODRC followed a 
                                                          
 79 See Ohio Famous Cases, DEATH PENALTY INFORMATION CENTER, 
http://www.deathpenaltyinfo.org/ohio-1#sent (“Richard Cooey challenged Ohio's lethal 
injection protocol, saying that it would cause a severely painful death. The U.S. Court of 
Appeals for the Sixth Circuit rejected his claim, and Cooey was executed on October 14, 
2008.”).   
 80 Id. (“Joseph Clark (May 2006), Christopher Newton (May 2007) and Romell Broom 
(September 2009)”).  
 81 See OHIO EXECUTION PROTOCOL, supra note 20 (On June 9, 2015 the ODRC amended the 
Execution Protocol to supersede the April 28, 2014 Execution Protocol). 
 82 See infra text accompanying notes 83-87.  
 83 See Capital Crimes, supra note 40 at 81 (“Clark murdered 22-year-old night clerk David 
Manning at a service station in Toledo. Clark demanded money and when Mr. Manning 
informed Clark that there was no money, Clark shot Mr. Manning once in the chest. After being 
arrested for robbing a bank, Clark admitted to the robbery-murder of Mr. Manning.”). 
 84 See Adam Liptak, Trouble Finding Inmate's Vein Slows Lethal Injection in Ohio, N.Y. 
TIMES (May 3, 2006), http://www.nytimes.com/2006/05/03/us/03inmate.html?_r=0. 
 85 Id. 
 86 See Sergo, supra note 3. 
 87 See Liptak, supra note 84. 
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parallel procedure that caused Christopher Newton to suffer during his execution.88  
Similar to the execution of Mr. Clark, the ODRC had difficulties finding a suitable 
vein for Mr. Newton.89  The execution team struggled for over an hour during this 
execution.90  
Unlike Mr. Clark or Mr. Newton, Romell Broom, is the “country’s only survivor 
of a botched lethal injection.”91  Mr. Broom suffered even longer during the execution 
process; two hours of pain while the execution team, again, tried to find a suitable 
vein.92  Not learning from prior mistakes, the ODRC stuck Mr. Boom 18 times with 
needles in fruitless attempt to commence the execution.93  Mr. Broom has appealed his 
case, and remains on death row until he is assigned a new execution date.94 
2. Ohio: Recent Issues with Lethal Injection 
Previously, Ohio used the drug pentobarbital in a one-drug cocktail to carry out 
the death sentence.95  However, in 2013, the supply of pentobarbital began to run dry 
and prisons all over the country, including Ohio, were in dire need of drugs to continue 
executing inmates on schedule.96  The suppliers, typically European manufacturers, 
either stopped producing these drugs or refused to sell these drugs to U.S. 
                                                          
 88 See Jim Leckrone, Ohio Executes Man Who Killed Prison Cellmate, REUTERS (May 24, 
2007), http://www.reuters.com/article/2007/05/24/us-execution-ohio-idUSN24371351
20070524. 
 89 Id.  
 90 Id. 
 91 See Ohio Supreme Court to Rule on Second Execution of Romell Broom, ASSOCIATED 
PRESS (June 3, 2014) http://www.theguardian.com/world/2014/jun/03/ohio-supreme-court-
romell-broom-botched-execution.  
 92 Id. (“An hour into the execution, the Department of Rehabilitation and Correction 
recruited a part-time prison doctor with no experience or training with executions to try – again, 
unsuccessfully – to find a vein.”).  
 93 Id. (“Broom has said he was stuck with needles at least 18 times, with pain so intense that 
he cried and screamed.”) 
 94 Id. (Mr. Broom’s attorneys are prepared to argue on his behalf that attempting to execute 
him again would “punish him twice for the same offense.” Id. “The State of Ohio argues that 
Broom never underwent the execution process since the procedure was called off before the 
drugs could be introduced into his veins.” Id.).  
 95 See State by State Lethal Injection, supra note 10.  
 96 See Id; see generally Johnson, supra note 12.  
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distributors.97  As a result, Ohio turned to compounding pharmacies to obtain drugs.98  
Ohio used a new two-drug cocktail of midazolam and hydromorphone, for the first 
time, on Mr. McGuire on January 14, 2014.99   However, after the execution of Mr. 
McGuire, the ODRC amended the execution protocol,100 replacing midazolam and 
hydromorphone with either pentobarbital or thiopental sodium.101  In Ohio’s recently 
updated execution protocol, the ODRC does not specify where to obtain the lethal 
injection drugs, but rather includes a host of potential suppliers including a 
manufacturer, distributor or compounding pharmacy.102  Compounding pharmacies 
pose a plethora of dangers because they “do not face the same approval process for 
their products that large manufacturers face, leading to concerns about the safety and 
efficacy of their products.”103 
                                                          
 97 See Johnson, supra note 12; see id. Cf. Denno, supra note 13, at ¶ 28 (“. . . pentobarbital 
was manufactured in Denmark by Lundbeck, Inc. Lundbeck announced a prohibition against 
use of the drug for executions, and Ohio's supply was subsequently exhausted. As a result, in 
October of 2013, Ohio adopted an “alternate” clinically untested drug mixture containing 
midazolam and hydromorphone”).  See also COUNCIL OF EUROPE PUBL’G & RENATE 
WOHLWEND LIECHTENSTEIN DELEGATION TO THE PARLIAMENTARY ASSEMBLY OF THE COUNCIL 
OF EUROPE, THE DEATH PENALTY ABOLITION IN EUROPE 55 (1999) (“Europe has become de facto 
a death-penalty free zone, with all of the Council of Europe’s forty-one member states either 
having abolished the death penalty, or having instituted a moratorium on executions”). 
 98 See Johnson, supra note 12.  
 99 See State by State Lethal Injection, supra note 10; see also Ohio Execution Protocol, 
supra note 20 (For the execution of Dennis McGuire, in January 2014, Ohio used the 
combination of midazolam and hydromorphone: “If a sufficient quantity of pentobarbital is not 
available, or if at any time the available pentobarbital is deemed unusable by the Medical Team, 
then the scheduled execution shall proceed with intravenous administration of midazolam and 
hydromorphone, in accordance with the terms of this policy”).   
 100 See Ohio Execution Protocol, supra note 20 (Replacing the combination of 
hydromorphone and midazolam, Ohio switched, on January 9, 2015, to pentobarbital or sodium 
thiopental:  
If a sufficient quantity of pentobarbital or thiopental sodium is available, then the 
scheduled execution shall proceed with intravenous administration of either 
pentobarbital or thiopental sodium, as determined by the Warden, in accordance with 
the terms of this policy. If a sufficient quantity of pentobarbital or thiopental sodium is 
not available, or if at any time the available pentobarbital or thiopental sodium is 
deemed unusable by the Medical Team, then the Warden shall consult with the Director 
and they shall notify the Governor.  
 101 See State by State Lethal Injection, supra note 10. 
 102 See Ohio Execution Protocol, supra note 20, at 8. (References pentobarbital or thiopental 
sodium, however lists suppliers of this drug vary which are still “in accordance with this 
policy”). 
 103 See Compounding Pharmacies and Lethal Injection, DEATH PENALTY INFORMATION 
CENTER, http://www.deathpenaltyinfo.org/compounding-pharmacies (last visited August 13, 
2015). 
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C. Compounding Pharmacies: A Way for Prisons to Bypass Regulation  
Compounding pharmacies are different from commercial pharmacies because they 
combine, mix, or alter drugs, which are used to meet the specific needs of an individual 
patient in response to a prescription.104  Even though a licensed pharmacist prepares 
compounded drugs, compounding pharmacies, as a whole, are not governed under the 
strict requirements of the Food and Drug Administration (“FDA”).105  This leaves the 
requirements and standards of the pharmacists to be regulated by state pharmacy 
boards, which vary from state to state.106 Compounding pharmacies may elect to 
become accredited by the Pharmacy Compounding Accreditation Board, however it 
is not a mandatory requirement.107  
Due to the lack of uniformity among the states to regulate compounding 
pharmacies, there was concern that some pharmacies were straying from the scope of 
traditional compounding practices.108  The FDA issued two reports revealing 
compounded drugs that failed safety and efficacy tests, as well as exposing serious 
illnesses and deaths that had occurred in association with compounded drugs.109  These 
reports failed to fix the problems compounding pharmacies posed and as a result in 
October 2012, the New England Compounding Center (“NECC”) was the root of a 
fungal meningitis outbreak in the United States.110  The drugs from this compounding 
pharmacy harmed over 700 people in 20 states, and left over 60 people dead.111 
Congress responded in November 2013 by passing the Drug and Quality Security 
Act.112 Encompassed within this Act is the Compounding Quality Act, which makes 
“a distinction between traditional compounders who work at the neighborhood 
                                                          
 104 Id. See also Denno, supra note 13, at 1367 (“Traditionally, all compounded drugs were 
custom-made in small batches for individual patients pursuant to a medical prescription. 
Physicians usually prescribe compounded medications when commercial drugs are unavailable 
or the use of existing commercial alternatives is inhibited by allergies”).  
 105 See Denno, supra note 13, at 1367. 
 106 Id. at 1367-68. See also State Regulation of Compounding Pharmacies, NAT’L 
CONFERENCE OF STATE LEGISLATURES (Oct. 1, 2014), http://www.ncsl.org/research/
health/regulating-compounding-pharmacies.aspx (“Every state has laws and regulations 
guiding pharmacy standards and requirements, addressing issues such as required licenses for 
each facility and for the credentialed pharmacists and other employees who work there”). 
 107 See Compounding Pharmacies and Lethal Injection, supra note 103. 
 108 See Denno, supra note 13, at 1370. 
 109 Id.  
 110 Id. at 1371.  
 111 See Compounding Pharmacies and Lethal Injection, supra note 103; see also T.R. 
Goldman, Regulating Compounding Pharmacies, HEALTH AFFAIRS (May 1, 2014), 
http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief_id=114 (“An FDA 
investigation later revealed that one-quarter of the steroid vials in an NECC bin contained a 
greenish black foreign matter. Hit with a raft of lawsuits, NECC declared bankruptcy, and in 
late 2013 the company's owners and its insurers reportedly reached an agreement in principle 
for a compensation fund of more than $100 million”). 
 112 See Denno, supra note 13, at 1374; see also Drug Quality and Security Act, 21 U.S.C. § 
503(b) (2013).  
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pharmacy and companies producing large quantities of compounded drugs without the 
need for a prescription.”113  This Act leaves regulation over traditional small-scale 
compounding pharmacies in the hands of the states.114  On the other hand, 
compounding pharmacies that mass-produce drugs may register with the FDA as 
outsourcing facilities.115  Under the Compounding Quality Act, outsourcing facilities 
are subject to rules on quality control and oversight.116  The loophole that puts prisons 
at an advantage is that large-scale compounding pharmacies are not mandated to 
register with the FDA.117  As a result, small-scale compounding pharmacies and large-
scale compounding pharmacies that opt out of FDA registration provide available 
means for prisons to purchase drugs for lethal injections.  
There are allegations that Ohio took advantage of this loophole by purchasing 
drugs from compounding pharmacies to carry out executions.118  Moreover, it is 
alleged that the ODRC purchased hydromorphone and midazolam from Hospira, Inc., 
a compounding pharmacy and distributor, which was utilized in the botched execution 
of Dennis McGuire.119  These matters are still pending in court, however, Ohio’s 
execution protocol allows the ODRC to obtain drugs from compounding 
pharmacies.120  As a result of the mishap by the ODRC concerning Dennis McGuire, 
and “[i]n light of the continuing need for discovery and necessary preparations related 
to the adoption and implementation of the new execution protocol,”121 all executions 
have been halted in Ohio until January 2016.122  
III. ARGUMENT: OHIO SHOULD PURCHASE DRUGS ONLY FROM FDA-REGISTERED 
OUTSOURCING FACILITIES  
The ODRC is following in the dark footsteps of Oklahoma. Ohio and Oklahoma 
have remarkably similar track records regarding lethal injection.123  Both states have 
                                                          
 113 See Goldman, supra note 111.  
 114 See Denno, supra note 13, at 1374. 
 115 Sabrina Tavernse, Bill on Drug Compounding Clears Congress a Year After a Meningitis 
Outbreak, N.Y. TIMES (Nov. 18, 2013), http://www.nytimes.com/2013/11/19/us/bill-on-
regulating-drug-compounding-clears-senate.html?module=Search&mabReward=relbias
%3Aw.  
 116 Id.  
 117 See generally Denno, supra note 13, at 1374 (“The Act refers to these large scale 
compounding manufacturers as outsourcing facilities and provides voluntary federal 
registration for outsourcing facilities, set to begin in fiscal year 2015”).  
 118 See In re Dennis R. McGuire, supra note 1, at ¶¶ 82-83.  
 119 See id. at  ¶ 73. It is also alleged “Hospira products have been used in at least five 
executions in the state of Ohio since at least November 2012.” Id. at ¶ 83.  
 120 See Ohio Execution Protocol, supra note 20 at 8.  
 121 See Execution Schedule, supra note 21.  
 122 See id. The first scheduled execution is Ronald Phillips on January 21, 2016. Id.   
 123 See generally Amanda Sakuma, Oklahoma Executes First Inmate Since Botched Lethal 
Injection, MSNBC (Jan. 15, 2015), http://www.msnbc.com/msnbc/first-lethal-injection-
oklahoma-botched-inmates-execution.  
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used a similar combination of drugs that resulted in botched executions.124  While 
Oklahoma hides behind its secrecy statute125 to protect the identities of the suppliers, 
Oklahoma has not tried to hide the fact that the Department of Corrections is open to 
using compounding pharmacies.126  Keeping in line with Oklahoma’s actions, Ohio, 
too, recently enacted a secrecy statute known as House Bill 663 (“HB 663”).127   HB 
663 protects the ODRC from what it has already done, provide immunity and 
confidentiality to all persons involved in the lethal injection process, including 
compounding pharmacies.128 
                                                          
 124 See generally Radelet, supra note 18.  
 125 See 22 Okla. Stat. Ann.tit. 22, § 1015(B) (West, Westlaw current with chapters of the 
Second Regular Session of the 54th Legislature (2014) effective September 1, 2014) (“The 
identity of all persons who participate in or administer the execution process and persons who 
supply the drugs, medical supplies or medical equipment for the execution shall be confidential 
and shall not be subject to discovery in any civil or criminal proceedings. The purchase of drugs, 
medical supplies or medical equipment necessary to carry out the execution shall not be subject 
to the provisions of the Oklahoma Central Purchasing Act”).  
 126 See Erik Eckholm, One Execution Botched, Oklahoma Delays the Next, N.Y. TIMES (Apr. 
29, 2014), http://www.nytimes.com/2014/04/30/us/oklahoma-executions.html?_r=0 (“Faced 
with shortages, Oklahoma and other states have turned to compounding pharmacies — lightly 
regulated laboratories that mix up drugs to order. Opponents have raised questions about quality 
control, especially after the widely reported dying gasps of a convict in Ohio for more than 10 
minutes, and an Oklahoma inmate’s utterance, “I feel my whole body burning,” after being 
injected with compounded drugs”).  
 127 See Death Penalty Legislation HB 663 Death Penalty Legislation, ACLU OF OHIO, 
http://www.acluohio.org/legislation/2013-2014-hb-663 (last visited Jan. 15, 2015) (“HB 663 
excludes from the definition of “public record” any information and records that relate in any 
manner to the execution of a death sentence. These records are made confidential, and not 
subject to any form of disclosure under the Public Records Law, as well as for the media and 
defense counsel during any legal cases. This includes determining the manufacturing origin of 
any drugs used during the lethal injection process or the combination of drugs that may be 
administered”); see also H.B. 663, 130th Gen. Assemb., Reg. Sess. (Oh. 2014) (“To amend 
section 149.43 and to enact sections 2949.221 and 2949.222 of the Revised Code to provide 
confidentiality and license protection for persons and entities involved in executing a sentence 
of capital punishment by lethal injection and to void as against public policy any agreement that 
prevents the supplying of any drug or drugs to be used in executing a sentence of capital 
punishment by lethal injection, and to amend the version of section 149.43 of the Revised Code 
that is scheduled to take effect on March 20, 2015, to continue the provisions of this act on and 
after that date”).  
 128 See Strauss, supra note 26; see also Ohio Execution Protocol, supra note 20, at 11 (“If 
the Warden determines that a sufficient quantity of pentobarbital is available and has been 
selected to be used, then a Drug Administrator shall prepare the execution drugs as follows:”  
Syringes 1 and 2: Five (5) grams of pentobarbital (under whatever name it may be 
available from a manufacturer, distributor or compounding pharmacy), 100 ml of a 
50mg/mL solution, shall be withdrawn and divided into two syringes labeled “1” and 
“2”.  
Syringes 3 and 4: Five (5) additional grams of pentobarbital (under whatever name it 
may be available from a manufacturer, distributor or compounding pharmacy), 100 ml 
of a 50mg/mL solution, shall be obtained and kept available in the Equipment Room, 
but need not be withdrawn into syringes unless the primary dose of five grams proves 
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A. Ohio and Oklahoma Have Used the Same Drug That Resulted in Botched 
Executions 
Ohio has used many different drugs to carry out lethal injections over the past few 
years.129  In 2009, Ohio used sodium thiopental,130 but switched to pentobarbital in 
2011.131  After the pentobarbital supply dried up, Ohio turned to a new two-drug 
combination of midazolam and hydromorphone.132  This two-drug combination was 
used for the execution of Dennis McGuire.133  Midazolam is used because it “is an 
anesthetic used sometimes in surgery, and hydromorphone is a narcotic pain killer.”134  
The midazolam is thought to render the inmate unconscious for the execution . . . and 
hydromorphone causes death by shutting down breathing and stopping the heart from 
beating.135  In response to Dennis McGuire, beginning in 2015, Ohio’s amended drug 
cocktail for lethal injection includes either pentobarbital, or a dose of thiopental 
sodium.136 
After the botched execution of Dennis McGuire, the administrators of his estate 
filed a complaint as a result of the misguided decisions of the ODRC.137   The 
complaint alleges that the ODRC adopted this compounded two-drug protocol without 
any prior clinical testing.138  Despite medical testimony and warnings, the ODRC went 
                                                          
to be insufficient for the procedure. These two additional syringes labeled “3” and “4” 
shall be kept available for contingent use. (emphasis added). 
A similar procedure is to be followed if the ODRC uses thiopental sodium. Id.  
 129 See State by State Lethal Injection, supra note 10 (Ohio used pentobarbital in 2011 and 
switched to midazolam and hydromorphone in 2014. Id. Recently, the ODRC announced plans 
to utilize sodium thiopental or pentobarbital. Id.).  
 130 See Julie Carr Symth and Andrew Welsh-Huggins, Ohio Clears Specialty Drug-Makers 
in Executions, ASSOCIATED PRESS (Oct. 4, 2013), http://bigstory.ap.org/article/ohio-announces-
alternative-lethal-injection-drug.  
 131 Id. 
 132 Compare State by State Lethal Injection, supra note 10, with In re Dennis R. McGuire, 
supra note 1, at ¶ 28 (“As described in greater detail herein, pentobarbital was manufactured in 
Denmark by Lundbeck, Inc. Lundbeck announced a prohibition against use of the drug for 
executions, and Ohio's supply was subsequently exhausted. As a result, in October of 2013, 
Ohio adopted an “alternate” clinically untested drug mixture containing midazolam and 
hydromorphone”).  
 133 Id.  
 134 Ben Brumfield, Arizona Execution Raises Questions Over Novel Lethal Injections, CNN 
(July 25, 2014), http://www.cnn.com/2014/07/24/justice/lethal-injection-controversy/.  
 135 Id.  
 136 See Andrew Welsh-Huggins, Ohio Drops 2-Drug Lethal Injection Method, Delays 
Execution, ABCNEWS (Jan. 8, 2015), http://abcnews.go.com/US/wireStory/apnewsbreak-ohio-
execution-drug-supply-expires-april-28082090.  
 137 See generally In re Dennis R. McGuire, supra note 1.  
 138 See id. at ¶ 39. (Prior to the execution, Dr. David Waisel “testified that midazolam can 
induce sedation, however a person can still consciously experience one's surroundings and feel 
pain and horrific stimuli, including air hunger, while under sedation.” Id. at ¶ 52. Furthermore, 
 
2015]   EXPLORING THE FLAWS IN THE OHIO EXECUTION PROTOCOL 111 
 
forward with the two-drug plan of hydromorphone and midazolam, which caused Mr. 
McGuire to experience intolerable pain and suffering.139  
Similarly enough, Oklahoma used midazolam as part of a three-drug combination 
in the botched execution for Clayton Lockett.140 After challenging Oklahoma’s secrecy 
statute, the Oklahoma Supreme Court denied to stay the execution of Clayton 
Lockett.141  Oklahoma then proceeded to use “midazolam, which causes 
unconsciousness; vecuronium bromide, which stops respiration; and potassium 
chloride, which stops the heart.”142  Similar to Ohio, which used an untested 
combination that included midazolam, the first time Oklahoma used midazolam was 
for the execution of Clayton Lockett.143  As a result, according to the Oklahoma 
Department of Corrections, Clayton Lockett later suffered a heart attack and died.144 
Midazolam contributed to both botched executions, as it was an ingredient in both 
drug cocktails for Mr. McGuire and Mr. Lockett. 
B. Compounding Pharmacies and Secrecy Statutes Do Not Provide Any Solutions    
Compounding pharmacies provide a convenient pathway for prisons to obtain 
drugs for lethal injections.  Ohio’s death sentence statute145 provides no guidance on 
where to purchase these drug cocktails, but the recently updated146 execution protocol 
explicitly permits the ODRC to utilize compounding pharmacies.147   The protocol 
specifically designates the Warden to be in charge “and responsible for carrying out 
                                                          
Dr. Waisel testified, “hydromorphone is not generally administered to induce amnesia.” Id. at ¶ 
54).   
 139 See id. at ¶ 63 (“Decedent repeated cycles of snorting, gurgling and arching his back, 
appearing to writhe in pain. It looked and sounded as though he was suffocating. His stomach 
was rising and falling quickly, as he took quick, shallow breaths. This continued for nearly 19 
minutes. The noises he made were audible the entire time, though they gradually quieted as he 
was dying. Decedent was conscious during the majority of this time”).  
 140 See Matt Pearce, Molly Hennessey-Fiske, Paresh Dave, Oklahoma Halts Double 
Execution After One is Botched, L.A. TIMES (Apr. 29, 2014), http://www.
latimes.com/nation/nationnow/la-na-nn-oklahoma-execution-20140429-story.html#page=1.   
 141 Lockett v. Evans, 330 P.3d 488, 491 (Okla. 2014) 
 142 See Pearce, supra note 140.  
 143 OKLA. DEP'T. OF PUB. SAFETY, THE EXECUTION OF CLAYTON D. LOCKETT, available at 
http://www.dps.state.ok.us/Investigation/14-0189SI%20Summary.pdf  (“The new three drug 
protocol utilized in this execution included the administration of midazolam, vecuronium 
bromide and potassium chloride. It was determined vecuronium bromide and potassium 
chloride had both been used in previous executions as the second and third drugs to be 
administered. This was the first Oklahoma execution where midazolam was used. On April 
14, midazolam was the newest drug added to the protocol after it was determined 
pentobarbital was not available”) (emphasis added).  
 144 See Pearce, supra note 140. 
 145 See Ohio Rev. Code Ann. § 2949.22 (West 2015) 
 146 See Ohio Execution Protocol, supra note 20, at 1 (Ohio’s protocol was updated April 14, 
2014 and again on January 9, 2015).  
 147 See id. at 8.  
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the death sentence on the date established by the Ohio Supreme Court.”148  Absent any 
statutory requirements, the execution protocol places the power in the Warden’s hands 
to determine what drugs to utilize, how much of each quantity shall be ordered and 
most important, where to purchase these drugs.149  In promulgating this new protocol, 
the ODRC included a host of potential suppliers, which gives a false appearance, to 
the public, of using a reputable and safe supplier.  The protocol allows the Warden to 
“order execution drugs from a licensed pharmacist at the Central Pharmacy at the 
Department on Mental Health,150 or any other licensed pharmacist.”151  However, a 
few pages later in the protocol, the ODRC expands the potential supplier list to include 
any manufacturer, distributor or compounding pharmacy.152  Ohio’s execution 
protocol does not address the real issue of the dangers posed by compounding 
pharmacies and includes all possible suppliers to maintain flexibility in times of 
disarray.  The newly updated execution protocol is expansive in providing options for 
the ODRC, but leaves prisoners with limited options.  Based on Ohio’s newly enacted 
secrecy statute, the enormous power of the Warden, and lack of adequate protections 
in the execution protocol, death row inmates can be subject to untested drugs from an 
unregulated compounding pharmacy. 
1. Ohio 
The administrators of Mr. McGuire’s estate named the ODRC’s Warden, Donald 
Morgan,153 as one of many defendants in the complaint filed on his behalf.  The 
complaint alleges that the Warden purchased hydromorphone and midazolam from 
Hospira, a compounding pharmacy and distributer.154  The plaintiffs have a good faith 
factual basis for this claim because in 2011 Hospira had manufactured and sold sodium 
                                                          
 148 Id. at 3. 
 149 See id. at 5-6. 
 150 Compare Ohio’s Pharmacy Service Center, http://mha.ohio.gov/Default.aspx?tabid=370 
(“The Ohio Pharmacy Service Center (OPSC) provides pharmaceuticals to governmental and 
qualifying entities in Ohio. Over-the-counter drugs, medical and laboratory supplies, personal 
care products and forms are also stocked”), with Ohio’s Central Pharmacy Inpatient, 
http://mha.ohio.gov/Default.aspx?tabid=367 (“Central Pharmacy Inpatient (CPI) has been 
providing comprehensive, centralized pharmaceutical services for more than 30 years. CPI 
focuses on best practices for patient care within state, county, or governmental inpatient settings. 
CPI offers competitively priced medications through consolidated purchasing, formulary 
management, medication monitoring, and coordinated care to ensure that health care dollars are 
spent wisely”), and Ohio’s Central Pharmacy Outpatient, http://mha.ohio.gov/Default.
aspx?tabid=368 (“CPO assists Community Mental Health Boards with the economic purchase 
and dispensing of psychotropic medications to needy clients meeting specific clinical and 
income eligibility criteria”).  
 151 See Ohio Execution Protocol, supra note 20, at 5.  
 152 See Ohio Execution Protocol, supra note 20, at 8.  
 153 See In re Dennis R. McGuire, supra note 1, at ¶ 10 (“Defendant Donald Morgan is the 
Warden at Southern Ohio Correctional Facility (“herein SOCF”). He is responsible for 
overseeing all operations at SOCF, including executions. He was present during Decedent's 
execution. He was acting in his official and individual capacity as such”).  
 154 Id. at ¶¶ 108-109.  
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thiopental to the ODRC to use in the executions for that year.155  Because Hospira 
previously sold compounded drugs,156 in conjunction with the present allegations, the 
ODRC is adhering to the new execution protocol that allows compounding pharmacies 
to provide the Warden’s choice of drugs. 
2. Oklahoma 
Oklahoma’s execution protocol differs from Ohio’s execution protocol regarding 
the suppliers of drugs.157  Oklahoma has passed not only a secrecy statute,158 to protect 
the identity of suppliers, but also incorporated the secrecy requirement in their 
execution protocol.159  Ohio too, passed a secrecy bill, mainly to shield the identity of 
                                                          
 155 See generally Letter from Keês Gioenhout, Vice President, Clinical Research and 
Development, Hospira, Inc., to Ohio Department of Rehabilitation and Correction (Mar. 31, 
2010 (available at http://www.deathpenaltyinfo.org/documents/HospiraMarch2010Statement.
pdf) 
 156 See id.  
 157 Compare Ohio Execution Protocol, supra note 20, at 8 (the ODRC is permitted to obtain 
drugs from a manufacturer, compounding pharmacy or distributer), with Oklahoma Execution 
Protocol, infra note 159, at 4 (the Oklahoma Department of Corrections is not permitted to 
disclose where the execution drugs are purchased, as disclosure is prohibited by their secrecy 
statute).   
 158 See 22 Okla. Stat. Ann. tit. 22, § 1015 (Westlaw 2014) (“The identity of all persons who 
participate in or administer the execution process and persons who supply the drugs, medical 
supplies or medical equipment for the execution shall be confidential and shall not be subject 
to discovery in any civil or criminal proceedings. The purchase of drugs, medical supplies or 
medical equipment necessary to carry out the execution shall not be subject to the provisions of 
the Oklahoma Central Purchasing Act”); see also Adam Lozeau, Obscuring the Machinery of 
Death: Assessing the Constitutionality of Georgia’s Lethal Injection Secrecy Law, 32 LAW & 
INEQ. 451, 467 (2014) (Oklahoma is not the only state with a secrecy statute and “in early 2013, 
Arkansas, South Dakota, and Tennessee amended their states' public records laws to shield the 
identities of the suppliers of lethal injection drugs from disclosure under their public records 
acts.”) Id. “A law enacted in March 2013 in Georgia went even further.” Id. “The law, known 
as the “Lethal Injection Secrecy Act,” states: 
The identifying information of any person or entity who participates in or administers 
the execution of a death sentence and the identifying information of any person or entity 
that manufactures, supplies, compounds, or prescribes the drugs, medical supplies, or 
medical equipment utilized in the execution of a death sentence shall be confidential 
and shall not be subject to disclosure under Article 4 of Chapter 18 of Title 50 or under 
judicial process. Such information shall be classified as a confidential state secret. Id.  
After Georgia’s secrecy statute was passed, an inmate filed for a stay of execution. 
See id. at 468. “The presiding judge delayed the execution, and just three days later, 
found the law unconstitutional under the Eighth Amendment of the federal 
Constitution and under the Separation of Powers Clause of the Georgia State 
Constitution.” Id. “The stay of execution is in effect until the Georgia Supreme Court 
rules on the constitutionality of the law.” Id.  
 159 See Oklahoma Execution Protocol, OKLAHOMA DEPARTMENT OF CORRECTIONS, http://
www.ok.gov/doc/documents/op040301.pdf (last updated Sept. 30, 2014) (“Maintaining 
confidentiality of identifying information regarding any person who participates in or performs 
any function of an execution. As defined in Oklahoma State Statute Title 22, Section 1015, “The 
identity of all persons who participate in or administer the execution process and persons who 
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the suppliers,160 but did not include the secrecy component in the updated execution 
protocol that took effect on January 9, 2015.  The Oklahoma Supreme Court held the 
secrecy statute constitutional,161 which poses a significant problem as it shields the 
company responsible for providing the drugs used in botched executions.  The media 
has alleged that Oklahoma resorted to compounding pharmacies as a result of drug 
shortages.162  Despite these allegations, people not directly involved in executions will 
never truthfully know where the Oklahoma Department of Corrections obtains drugs.  
3. Secrecy Statutes Provide No Cure to Botched Executions 
Ohio is similar to Oklahoma in that both Departments of Corrections seem to have 
a false sense of security.  For Oklahoma, the secrecy statute did not provide a solution 
to the botched execution of Clayton Lockett.  Looking at Oklahoma, Ohio should note 
that the neither a secrecy statute nor including a vague host of suppliers solves the 
problems that resulted from the botched execution of Dennis McGuire, or provides a 
solution for upcoming executions.  Both states have the appearance of hiding behind 
a cloak of invisibility163 instead of addressing the root of the problem—where these 
drugs are purchased.  Instead of covering up the identities of suppliers,164 Ohio should 
be forthcoming on where they obtain drugs for lethal injection for the bodily health 
and respect of the inmate.  The ODRC seems to be covering their tracks leading up to 
the executions, knowing that the statute will protect and cover up suspicious behavior 
by persons involved with lethal injection.  Ohio’s enactment of HB 663 was 
conveniently passed after Oklahoma’s mishaps with Clayton Lockett, the enactment 
of Oklahoma’s secrecy bill and the ODRC’s botched execution of Dennis McGuire.  
In reality, Ohio’s enactment of HB 663 is a band-aid on open wound that needs stitches 
to heal properly.  
Ohio should exclude the use of small-scale state regulated compounding 
pharmacies and large-scale compounders that do not elect to register with the FDA as 
an outsourcing facility.  Ohio should only purchase drugs for lethal injections from an 
FDA-registered outsourcing facility.  Ohio would be taking a small, albeit proactive 
step, to ensure that the drugs are coming from a pharmacy with FDA oversight.  
                                                          
supply the drugs, medical supplies or medical equipment for the execution shall be confidential 
and shall not be subject to discovery in any civil or criminal proceedings. The purchase of drugs, 
medical supplies or medical equipment necessary to carry out the execution shall not be subject 
to the provision of the Oklahoma Central Purchasing Act”).  
 160 See Death Penalty Legislation, supra note127. 
 161 See Lockett v. Evans, 330 P.3d 488, 491 (Okla. 2014) (holding that the “secrecy provision 
of death sentence statute did not violate inmates' constitutional right of access to the courts”).  
 162 See Eckholm, supra note 126 (“Faced with shortages, Oklahoma and other states have 
turned to compounding pharmacies — lightly regulated laboratories that mix up drugs to 
order”).  
 163 See generally Louis E. Wolcher, Keynote Address, 17 J. L. BUS. & ETH. 9, 13 (2011) 
(Referencing Plato and the “ancient fable of the Ring of Gyes. This magical ring allowed its 
wearer to become invisible at will, and I wonder, as Plato did more than two millennia ago, 
whether someone who could put it on would behave the same way if she knew that she never 
had to fear the personal consequences of her actions”); see also Plato, REPUBLIC: BOOK II.  
 164 See Death Penalty Legislation, supra note 127.  
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C. Solutions 
1. Outsourcing Facilities Versus State-Regulated Compounding Pharmacies 
a. Outsourcing Facilities: More Regulations Required by the FDA 
Purchasing drugs from outsourcing facilities would assist the ODRC in narrowing 
down the current supplier list in the execution protocol to a more reliable provider. 
Compounding pharmacies that elect to register with the FDA as an outsourcing 
facility165 must comply with CGMP166 [current good manufacturing practices] 
requirements, be inspected by FDA, report adverse events and, provide the FDA with 
certain information about the products they compound.167  
The FDA promulgated a guide to illustrate the their position on current good 
manufacturing practices168 pertaining to Compounding Quality Act, specifically 
section 503(B) within the Food, Drug and Cosmetic Act.169  This draft contains 
detailed explanations regarding: “facilities designs, procedures for maintaining 
suitable facilities, environmental and personnel monitoring, equipment and container 
                                                          
 165 See Information Concerning Outsourcing Facilities Registration, U.S. FOOD AND DRUG 
ADMINISTRATION, 
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompoundi
ng/ucm389118.htm (last updated Mar. 14, 2014) (for more information on how to register as an 
outsourcing facility see submission #1); see also 
Registration for Human Drug Compounding Facilities Under Section 503B of the Federal 
Food, Drug and Cosmetic Act, Draft Guidance, U.S. FOOD AND DRUG ADMINISTRATION (Dec. 
2013), http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guid
ances/ucm377051.pdf.  
 166 Drug Applications and Current Good Manufacturing Practice (CGMP) Regulations, 
U.S. FOOD AND DRUG ADMINISTRATION, http://www.fda.gov/Drugs/DevelopmentApproval
Process/Manufacturing/ucm090016.htm (last updated Sept. 12, 2014) (“FDA ensures the 
quality of drug products by carefully monitoring drug manufacturers' compliance with its 
Current Good Manufacturing Practice (CGMP) regulations.  The CGMP regulations for drugs 
contain minimum requirements for the methods, facilities, and controls used in manufacturing, 
processing, and packing of a drug product.  The regulations make sure that a product is safe 
for use, and that it has the ingredients and strength it claims to have”).  
 167 Protecting the Public Health: Examining FDA’s Initiatives and Priorities: Before the S. 
Comm. on Health, Education, Labor and Pensions, 113th Cong. 22 (2014) (statement of 
Margaret A. Hamburg, M.D., Comm’r of Food and Drugs, Food and Drug Administration), 
available at http://www.hsdl.org/?view&did=754891.  
 168 See Guidance for Industry Current Good Manufacturing Practice—Interim Guidance for 
Human Drug Compounding Outsourcing Facilities under Section 503B of the FD&C Act, Draft 
Guidance, U.S. DEP’T OF HEALTH AND HUMAN SERVICES, U.S. FOOD AND DRUG 
ADMINISTRATION, CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) (July 2014),  http://
www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UC
M403496.pdf.    
 169 Id. at 1 (“This interim guidance describes FDA’s expectations regarding compliance with 
current good manufacturing practice (CGMP) requirements for facilities that compound human 
drugs and register with FDA as outsourcing facilities under section 503B of the Federal Food, 
Drug, and Cosmetic Act (FD&C Act)”).   
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guidelines, production, testing, and packaging and quality assurance.”170  This guide 
includes a section that is likely related to the New England Compounding Pharmacy 
fiasco,171 which reads: “[c]ertain elements of facility design are considered critical to 
ensuring the quality of compounded sterile drug products.”172  “For example, all 
processing and controlled areas must be clean and free of visible signs of filth, dirt, 
mold or mildew, insects, and inappropriate items or debris.”173  
Furthermore, outsourcing facilities must comply with written procedures for 
production and process controls to ensure that the consistent production of a drug 
meets the applicable standards of identity, strength, quality, and purity.174  One benefit 
of electing to use outsourcing facilities is that the FDA requires testing before a 
compounded drug is released for distribution.175   Prior testing will assist the ODRC 
because outsourcing facilities are required to warrant that the finished product contains 
the proper identity and strength of the active ingredient.176  Moreover, by purchasing 
drugs from outsourcing facilities, the ODRC will know that the drugs comply with 
proper packaging requirements,177 be of proper quality, and remain sterile through the 
labeled expiration date.178  These regulations allow the ODRC to know that the drugs 
will produce the intended effects and work properly up until expiration.  
Most notable are the strict regulations regarding the equipment utilized in the 
compounding process, as well as actual testing before the drug is distributed.179  Before 
a product can even hit the marketplace, outsourcing facilities must have scientifically 
proven data to support their reasons for using certain containers or enclosures for the 
compounded drugs.180 After selecting appropriate containers or enclosures, these 
products must be tested to determine whether they can “maintain the quality of the 
finished drug product and sterility over the expiry period.”181  
                                                          
 170 See Guidance for Industry Current Good Manufacturing Practice, supra note 168 (see 
table of contents).  
 171 See text accompanying notes 110-111.  
 172 See Guidance for Industry Current Good Manufacturing Practice, supra note 168, at 3.  
 173 See id.  
 174 Id. at 11; see generally 21 C.F.R. § 211.100 (West 2014).  
 175 See Guidance for Industry Current Good Manufacturing Practice, supra note 168, at 14; 
see also 21 C.F.R. § 211.165 (West, Westlaw current through Oct. 30, 2014), see also 21 C.F.R. 
§ 211.167 (West 2014).  
 176 See Guidance for Industry Current Good Manufacturing Practice, supra note 168, at 14; 
see also 21 C.F.R. § 211.160(b) (West 2014).  
 177 See Guidance for Industy Current Good Manufacturing Practice, supra note 168, at 19; 
see also 21 C.F.R. § 211.122 (West 2014).  
 178 See Guidance for Industry Current Good Manufacturing Practice, supra note 168, at 18; 
see also 21 C.F.R. § 211.166 (West 2014). 
 179 See Guidance for Industry Current Good Manufacturing Practice, supra note 144, at 7; 
see also 21 C.F.R § 211.160(b) (West, Westlaw current through Feb. 5, 2015); 21 C.F.R. § 
211.84(d)(3) (West, Westlaw current through Feb. 5, 2015); 21 C.F.R. § 211.184 (West 2015).  
 180 Id.  
 181 Id.  
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After selecting containers, outsourcing facilities must engage in pre-releasing 
testing.182 Facilities must compare the projected output and the actual output of the 
drug to fix any inconsistencies.183  Any differences between the projected and actual 
outcome of compounded drugs are considered indicators of potential problems with 
production and must further be investigated and re-tested.184  The mandate of pre-
release testing guarantees drugs meet the “final product specifications before their 
release for distribution.”185  Outsourcing facilities are required to establish quality 
control units which are responsible for ensuring that the finished drug product is not 
released until this testing is conducted and the results confirm that the finished drug 
product meets certain specifications.186  As an added layer of protection, drugs that are 
stored for long periods must be retested to verify the proper identity, strength, quality, 
and purity, or after any exposure to natural elements such as air or heat.187  Pre-release 
testing will benefit prisons because the compounded drugs will not only be sterile, but 
will have also gone through prior testing such that the drugs will produce the intended 
results.  By leaving the testing requirements to the outsourcing facility, prisons will 
not have to experiment with these drugs on inmates in carrying out a death sentence.  
All of the requirements imposed on outsourcing facilities act as additional 
precautionary measures, which will curb the likelihood of another botched execution.  
When a compounding pharmacy registers as an outsourcing facility the company 
is taking a proactive step that illustrates transparency regarding the compounding 
processes.  “Once an outsourcing facility is registered, the FDA will inspect it within 
two months of registration.”188  After the initial inspection, subsequent inspections will 
be based on multiple factors including: 
the compliance history of the outsourcing facility; the record, history, and 
nature of recalls linked to the outsourcing facility; the inherent risk of the 
drugs compounded at the outsourcing facility; the inspection frequency and 
history of the outsourcing facility, including whether the outsourcing 
facility has been inspected within the last 4 years; and whether the 
outsourcing facility has registered as an entity that intends to compound 
drugs in shortage.189 
                                                          
 182 See Guidance for Industry Current Good Manufacturing Practice, supra note 168, at 14; 
see also 21 C.F.R. § 211.165 (West 2014 ); see also 21 C.F.R. § 211.167 (West 2014).   
 183 Id. at 11. 
 184 Id.  
 185 Id. at 14.  
 186 Id.; see also 21 C.F.R. §  211.22 (West 2014).  
 187 Id. at 10. 
 188 See Information Concerning Outsourcing Facilities Registration, supra note 165.  
 189 See Information Concerning Outsourcing Facilities Registration, supra note 165 (“It is 
important to note that “registration means only that FDA has received the information required 
to register the facility. It does not mean that the facility is making FDA-approved drugs and it 
does not mean it is in compliance with current good manufacturing practice requirements…”) 
(emphasis added).  
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There are some drawbacks when a pharmacy registers as an outsourcing facility. 
Most importantly, drugs compounded at an outsourcing facility are not FDA 
approved;190 however purchasers, such as the ODRC, will know that the facility is 
complying with good manufacturing practices.191  Additionally, when a pharmacy 
registers as an outsourcing facility, an annual establishment fee will be imposed upon 
the company.192  
There are drawbacks associated when registering as an outsourcing facility, but the 
benefits of subjecting the compounding process to FDA oversight provide a better 
safeguard for prisons.  By choosing to comply with FDA regulations, “compounders 
will have an incentive to register as outsourcing facilities in order to enjoy a market 
advance, because their products may be perceived to be safer than those produced by 
other compounders.”193  Even more beneficial is that the ODRC has several options 
for choosing an outsourcing facility because as of February 28, 2014, 30 companies 
had registered as outsourcing facilities.194  One outsourcing facility is located in 
Poland, Ohio,195 which is approximately five hours196 from Lucasville, Ohio, where 
inmates are executed at the Southern Ohio Correctional Facility.197 
b. Small-Scale State Regulated Compounding Pharmacies Are Inadequate 
Unlike outsourcing facilities, small-scale compounding pharmacies are regulated 
by state pharmacy boards.198  State pharmacy boards can be as large as 20 members, 
                                                          
 190 See id. (“Drugs made by compounders, including those made at human drug 
compounding outsourcing facilities, are NOT FDA-approved. This means that they have not 
undergone the same premarket review as approved drugs. They lack an FDA review of safety 
and efficacy and of manufacturing quality”). 
 191 See id. (“Although the drugs will not be FDA approved, purchasers of drugs compounded 
at a registered outsourcing facility that has had a recent satisfactory FDA inspection will have 
some assurance that the conditions at that facility met applicable current good manufacturing 
practice standards at the time of the inspection, and the compounded drugs are labeled with the 
required information”).  
 192 See Drug Quality and Security Act Boost Regulation of Compounders, Clarifies FDA 
Oversight Authority, FDA Enforcement Manual Newsletter (Food and Drug Administration), 
Jan. 2014, at 2 (“In addition, outsourcing facilities will be subject to an annual establishment 
fee of $15,000, adjusted for inflation. A reduced fee for small businesses -- one-third of the full 
fee amount -- will apply to compounders with annual gross sales of $1 million or less. A fee in 
the same amount will be charged for each re-inspection of an outsourcing facility”).  
 193 Id. (“In addition, outsourcing facilities -- unlike other compounders -- will be able to 
compound a drug without having a patient-specific prescription”).  
 194 See  Fed. Drug Adm’r., Registered Outsourcing Facilities, U.S. FOOD AND DRUG 
ADMINISTRATION, (Aug. 7, 2015) http://www.fda.gov/Drugs/GuidanceComplianceRegulatory
Information/PharmacyCompounding/ucm378645.htm.  
 195 See id.  
 196 See MapQuest directions from Lucasville, Ohio to Poland, Ohio, http://www.mapquest.
com/#f9c3783bd47f9f6509621695.   
 197 See Capital Punishment in Ohio, supra note 27 (“The "Death House" remains at the 
Southern Ohio Correctional Facility”).  
 198 See Denno, supra note 13, at 1367-68.  
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or as small as five members, all who are appointed by the Governor. 199  State 
pharmacy boards are responsible for all pharmacy practices that occur in the state.200  
Inspections of pharmacies occur in different fashions: a scheduled in-person 
inspection, a surprise inspection, or a self-inspection.201  Self-inspections are 
troublesome because pharmacies submit responses to questionnaires essentially 
declaring the pharmacy is in compliance with state law.202  Self-inspections may lead 
pharmacies to exceed the scope of traditional pharmaceutical practices, without any 
oversight or punishment from a state pharmacy board.  
 A congressional report highlighted the states overall inabilities to regulate 
compounding pharmacies.203  State pharmacy boards have trouble overseeing 
pharmacies physically located in the state and therefore can not oversee compounding 
pharmacies in other states who sell and ship compounded drugs across state lines.204  
Further complicating the regulatory scheme is the focus of enforcement efforts.  State 
pharmacy boards focus their efforts on licensing issues, billing violations, failing to 
register with the state, failing to have a licensed pharmacist on site, and violations 
related to the use and distribution of drugs.205  Pharmacy boards do not place enough 
attention on the safety or scope of compounding practices.206 
The role state pharmacy boards play in the enforcement of pharmaceutical 
practices appears to be very low. This congressional report found that states do not 
have the proper resources, as evidenced by finding number one: 
state boards of pharmacy generally do not know which pharmacies engage 
in compounding, do not know whether pharmacies ship compounded drugs 
across state lines, and do not know which pharmacies manufacture large 
quantities of compounded drugs. In many cases, states are incapable of 
even providing accurate information regarding the numbers of registered 
pharmacies in their states.207 
It is easy to see why many state pharmacy boards do not play an active role in the 
oversight of compounding pharmacies—a majority of states do not even require a 
compounding license or permit.208  Even more troublesome is that only 13 state 
                                                          
 199 See Edward J. Markey et al., State of Disarray, How State’s Inability to Oversee 
Compounding Pharmacies Puts Public Health at Risk, Homeland Security Digital Library (Apr. 
15, 2013), http://www.hsdl.org/?%20view&did=735130 (Written by Congressman Ed Markey 
(D-MA), Henry Waxman (D-CA), John Dingell (D-MI), Frank Pallone (D-NJ) and Diana 
Degette (D-CO)) at 10. 
 200 See id at 2. 
 201 Id. at 10.  
 202 See id.  
 203 See id. 
 204 Id. at 12.  
 205 Id. at 12-13. 
 206 Id. at 13. 
 207 Id. at 15.  
 208 Id. (Mississippi and Missouri are the only states that require a specific permit or license 
to track certain compounding practices. Id.) 
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pharmacy boards know which pharmacies are compounding sterile drugs, and Ohio’s 
pharmacy board is not included.209   
Another drawback of state regulation is the lack of records kept during inspections. 
Without records, states cannot evaluate which pharmacies perform reputable and 
lawful compounding practices, or pharmaceutical practices in general.  In fact, over 
20 states do not keep any type of historical records of inspection, nor track problems 
related to compounding.210  This means that states have limited knowledge of issues 
regarding contamination, cleanliness, drug potency, drug safety and bulk 
manufacturing, just to name a few.211  Even with a lack of inspection records, states 
have reported over 2,000 disciplinary actions instituted against compounding 
pharmacies. Disciplinary actions have stemmed from: 
issues of unsafe storage, compounding copies of commercially available 
drugs, compounding without a prescription, issues with potency, problems 
with sterility, use of improper ingredients, and manufacturing large 
quantities of drugs outside the scope of a pharmacy license.212 
As most states do not keep any type of inspection records, one can expect that most 
states do not memorialize the disciplinary process with great detail.213  Therefore, the 
public is left in the dark as to what pharmaceutical practices were violated, and what, 
if any, disciplinary actions were taken against a compounding pharmacy.214  Even 
though a few states publish enforcement actions taken against compounding 
pharmacies on state websites, the public is still left in the dark.215  Most websites do 
not provide enough information for the public to understand the nature of the violation, 
making it virtually impossible to know what prior compounding issues a facility 
underwent.216  The lack of adequate record keeping highlights the ineffectiveness of 
state pharmacy boards to regulate compounding pharmacies.  
State pharmacy boards are also faced with financial restraints and lack of 
manpower.217 Generally, state pharmacy boards are composed of few representatives 
who must operate with a very limited budget allocated by the state.218  Because budgets 
vary from state to state, compounding pharmacies in different states must succumb to 
                                                          
 209 Id. at 17; see also id. at 14. (Only thirteen state boards of pharmacy know which 
pharmacies are providing sterile compounding services and only five of these states have 
inspectors that are trained to identify problems with sterile compounding. The thirteen state 
pharmacy boards include: Alabama, California, Connecticut, Delaware, Iowa, Idaho, 
Massachusetts, New Jersey, New York, Oklahoma, Texas, Virginia and Washington).  
 210 Id. at 20.  
 211 See id.  
 212 Id. at 20.  
 213 Id.  
 214 Id. 
 215 Id. 
 216 Id.  
 217 Id. at 25.  
 218 Id.  
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varying standards and frequencies of inspections.219  For example, “Nevada currently 
has a pharmacy board operating budget that provides for approximately $3,260 per 
pharmacy, for which the board is responsible for inspecting, while Indiana’s board of 
pharmacy has an operating budget that provides for approximately $173 per 
pharmacy.”220  The lack of financial resources poses the question of whether state 
pharmacy boards can provide adequate oversight of the compounding process to 
ensure the safety of the drugs and protect the public health in general.221  Limited 
monetary resources go hand in hand with fewer inspectors employed by state 
pharmacy boards. For example, Ohio employs 22 inspectors, which is a significant 
number compared to its counterpart states, Vermont, Hawaii and Wyoming, all of 
which employ fewer than two pharmacy inspectors.222  Even if state pharmacy boards 
desired to provide and keep adequate inspection and disciplinary records, it would be 
virtually impossible due to insufficient capital. 
These findings provide only a slight glimpse into the inadequacy of state pharmacy 
boards to safely and properly regulate compounding pharmacies. The FDA mandates 
more requirements for outsourcing facilities, which assure prisons that the 
compounded drugs are suitable for the intended uses.  
2. Compounding Pharmacies Have Been Linked to Pain and Suffering 
a. Ohio 
At 10:31 a.m. after the first syringe was injected223 into Dennis McGuire, he took 
a deep breath and clenched his hands into fists.224  “He then made a very loud snorting 
sound which could be heard in the witness room without any sound amplification.”225  
Mr. McGuire then proceeded to “make extremely loud noises like he was grunting and 
fighting for air at the very same time.”226  This was one of Ohio’s longest executions 
since Ohio reinstated capital punishment in 1999.227  
Among the many allegations against the Warden and the ODRC, the family of 
Dennis McGuire believes that the execution caused Mr. McGuire to suffer serious 
physical harm, serious psychological harm and a lingering, undignified death in which 
he endured needless pain and suffering during his execution.228  Purchasing drugs from 
compounding pharmacies attributed to the pain and suffering that ultimately led to the 
botched execution of Dennis McGuire.  Furthermore, utilizing compounding 
                                                          
 219 Id.  
 220 Id. 
 221 Id.  
 222 Id. at 26. 
 223 See In re Dennis R. McGuire, supra note 1, at ¶ 56.  
 224 Id. at ¶ 59. 
 225 Id.  
 226 Id. at ¶ 61. 
 227 See Gary Strauss, Ohio Killer's Slow Execution Raises Controversy, USA TODAY (Jan. 
16, 2014), http://www.usatoday.com/story/news/nation/2014/01/16/ohio-killer-executed-with-
new-lethal-drug-combo/4512651/.  
 228 See In re Dennis R. McGuire, supra note 1, at ¶ 100.  
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pharmacies is in direction contradiction with the Ohio death sentence statute,229 which 
requires “lethal injection to quickly and painlessly cause death.”230  Further 
complicating the execution process is that the terms quick and painless are not defined 
statutorily.231  This gives prisons unfettered discretion in determining what constitutes 
quick and painless—as the execution is underway.  Only after the death of an inmate, 
can a court determine whether the execution procedures complied with the ambiguous 
statutory requirements—but the damage has already been done. That death row inmate 
has already suffered for a period of time based on the standards and procedures 
employed by the prison. 
b. Oklahoma 
Clayton Lockett was executed under Oklahoma’s protocol on April 29, 2014.232  
Similar to Dennis McGuire, Mr. Lockett also experienced horrific complications 
namely with the IV used.233  Once Mr. Lockett’s execution was stopped, he later died 
in the execution chamber.234 As a result, the Governor of Oklahoma ordered an 
independent review to look into the procedures employed prior to and during Mr. 
Lockett’s execution.235  This report revealed that the IV had been infiltrated that lead 
to blood and a clear liquid appearing on Mr. Lockett’s skin.236  Further, the physician 
in the execution chamber noticed significant swelling on Mr. Lockett’s body.237  As a 
result, the execution was halted just as Mr. Lockett was being injected with potassium 
chloride.238  The toxicology report indicated that Mr. Lockett’s blood contained a small 
amount of the lethal injection drugs.239  Arguably, the execution was halted for a 
variety of reasons including the faulty IV, which was injecting drugs which may have 
been purchased from a compounding pharmacy.  The Oklahoma protocol and secrecy 
                                                          
 229 See Ohio. Rev. Code § 2949.22. 
 230 Id., see also In re Dennis R. McGuire, supra note 1, at ¶¶ 55, 66 (highlighting the 
execution began at 10:27 a.m. and he was pronounced dead at 10:53 a.m., it took over 20 
minutes to die); see also Sergo, supra note 3 (“According to a 2002 study in the Journal of 
Forensic Science, the average length of time from the first injection to death is 8.4 minutes”). 
 231 See Ohio. Rev. Code § 2949.22. 
 232 See The Execution of Clayton D. Lockett, OKLA. DEP’T OF PUBLIC SAFETY, http://
www.dps.state.ok.us/Investigation/14-0189SI%20Summary.pdf (last visited Nov. 3, 2014).  
 233 Id. at 1. 
 234 Id. 
 235 Id. at 2 (On “April 30, Governor Fallin issued Executive Order 2014-11, which appointed 
Secretary of Safety and Security and Department of Public Safety (DPS) Commissioner Michael 
Thompson to conduct an independent review of the events leading up to and during Lockett’s 
execution”). 
 236 Id. at 18. 
 237 Id.  
 238 Id. 
 239 Id. at 18 (“On May 14 and May 19, OCME [Oklahoma County Medical Examiner] 
documented the toxicology results they received from NMS Labs on an aliquot of the femoral 
blood sample they obtained from Lockett’s body on April 30. The results indicated a midazolam 
concentration of 0.57 mcg/mL and a vecuronium concentration of 320 ng/mL”).  
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statute did not provide for a seamless execution, as it was eventually halted in the 
middle of the execution.240  Both of the botched executions in Ohio and Oklahoma 
illustrate the need to change both execution procedures, which can start with the 
pharmacies supplying these drugs.  
IV. RECOMMENDATIONS TO THE OHIO DEPARTMENT OF REHABILITATION AND 
CORRECTION 
Below is a list of recommendations for the Ohio Department of Rehabilitation and 
Correction’s current execution protocol pertaining to lethal injection.  These 
recommendations may assist in curtailing another botched execution and will provide 
more transparent information to officials involved in the execution process.  The 
ODRC should consider the following regarding the current lethal injection protocol: 
A. Update the execution protocol sections titled: ‘EXECUTION PREPARATION—
APPROXIMATELY 14 DAYS PRIOR TO THE EXECUTION’241 AND ‘EXECUTION 
PREPARATION—APPROXIMATELY 30 DAYS PRIOR TO THE EXECUTION’242 to 
explicitly direct the Warden to purchase drugs only from an FDA-registered 
outsourcing facility.  
B. Update the execution protocol sections titled: EXECUTION PREPARATION—
APPROXIMATELY 14 DAYS PRIOR TO THE EXECUTION’243 AND ‘EXECUTION 
PREPARATION—APPROXIMATELY 30 DAYS PRIOR TO THE EXECUTION’244 to 
explicitly prohibit the Warden from purchasing drugs from small-scale state 
regulated compounding pharmacies and large-scale compounding pharmacies 
that do not elect to register with the FDA as an outsourcing facility. 
C. Modify the execution protocol section titled: DRUG PREPARATION245 to only 
permit the Warden to use drugs from outsourcing facilities and prohibit the 
use of drugs purchased from small-scale state regulated compounding 
pharmacies and large-scale compounding pharmacies that do not elect to 
register with the FDA as an outsourcing facility.  
D. Include a list of potential outsourcing facilities in the execution protocol 
section titled: DRUG PREPARATION246—to provide another option of 
purchasing drugs for lethal injection. 
The above-mentioned suggestions are not a complete solution to the various issues 
related to the execution process.  However, these recommendations may help curtail 
the likelihood of another botched execution from occurring in Ohio.  Using 
outsourcing facilities provides transparency of the drug compounding process, even 
in light of Ohio’s recently enacted secrecy statute.247  Purchasing drugs for lethal 
injection from an outsourcing facility removes the experimentation factor of whether 
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the drugs will properly perform because of the strict FDA requirements.  The FDA 
requirements provide extremely detailed safety, testing and packaging mandates that 
ensure compounded drugs will produce the intended effect.248  Even in light of Ohio’s 
recently enacted secrecy statute,249 the ODRC can still adjust the execution protocol 
to list outsourcing facilities as a potential provider of lethal injection drugs.250  If the 
general option of purchasing from an outsourcing facility is added to the execution 
protocol, the ODRC could still comply with the secrecy statute251 by omitting specific 
names of outsourcing facilities. These recommendations will provide more concrete 
regulation to the execution protocol and assist in lowering the chances of another 
botched execution from occurring. 
V. CONCLUSION 
The ODRC is not immune to unplanned events occurring during the execution 
process. In response to the recent botched execution of Mr. McGuire, and the previous 
botched executions of three other inmates, the ODRC should implement several 
changes to the current execution protocol.  The ODRC continues to amend the drugs 
used for lethal injection, when the real source of botched executions may not be the 
actual drugs utilized, but may be where the drugs are purchased.   
Previously, Ohio turned to compounding pharmacies to purchase these drugs—
facilities that have limited regulation and oversight.252 Compounding pharmacies are 
traditionally regulated by state pharmacy boards, which typically cannot provide 
enough oversight to regulate the compounding process.253  However, compounding 
pharmacies may elect to register with the FDA as outsourcing facilities.254  
Outsourcing facilities are required to follow strict FDA guidelines when compounding 
drugs to ensure the drugs produce the intended results.255  The FDA is better equipped 
to regulate the compounding process, as outsourcing facilities must begin the 
compounding process by testing containers or enclosures that are appropriate for 
certain compounded drugs.256  Furthermore, outsourcing facilities must go through 
pre-releasing testing of compounded drugs to ensure the proper identity, strength, 
quality, and purity.257  When a compounding pharmacy voluntarily elects to register 
as an outsourcing facility, the compounding process must abide by more stringent 
safeguards, which in turn assists prisons when purchasing drugs for lethal injection.  
                                                          
 248 See generally text accompanying note 170. 
 249 Id. 
 250 See text accompanying note 245. 
 251 See generally Death Penalty Legislation, supra note 127. 
 252 See Denno, supra note 13. 
 253 See Markey, supra note 200. 
 254 See Information Concerning Outsourcing Facilities Registration, supra note 165. 
 255 See Protecting the Public Health, supra note167. 
 256 See text accompanying note 180. 
 257 See text accompanying note 174. 
 
2015]   EXPLORING THE FLAWS IN THE OHIO EXECUTION PROTOCOL 125 
 
Unlike FDA regulated outsourcing facilities, state pharmacy boards regulate 
small-scale compounding pharmacies.258  However, state pharmacy boards do not have 
the financial resources or human capital to adequately oversee the compounding 
process.259  State pharmacy boards do not focus their efforts to oversee the 
compounding process, unlike the FDA.  Even more problematic is that most state 
pharmacy boards do not keep any type of adequate records pertaining to inspection or 
disciplinary actions.260  Without records, the public, people who use drugs purchased 
from state regulated compounding pharmacies, including prisons, are unaware of the 
compounding practices.  Due to the lack of transparency and ineffective management 
of state regulation, state pharmacy boards cannot ensure adequate oversight.  The FDA 
provides more reliable and rigorous requirements for the compounding process and 
has the ability to oversee the entire compounding process—down to the very container 
used to house the compounded drug.  
The main priority for the ODRC should be to change the current practice of 
utilizing unregulated and state-regulated compounding pharmacies.  Instead, the 
ODRC should be more forthcoming when purchasing these drugs to ensure that the 
drugs are purchased from a safe supplier with adequate FDA oversight.  Ohio should 
note that the prior mistakes during executions could have been the result of where the 
ODRC obtained these drugs, and not the actual drug utilized.  To start, the ODRC 
must be more specific in the lethal injection protocol instead of including a long list 
of potential suppliers.  Ohio has the option to amend the execution protocol to add 
outsourcing facilities as a choice for purchasing drugs.  Further, the ODRC can choose 
to eliminate purchasing drugs from unregulated compounding pharmacies for all 
upcoming executions.   
Outsourcing facilities abide to more stringent safety requirements that can assist 
in preventing another botched execution from occurring.  While outsourcing facilities 
cannot guarantee a seamless execution, the compounding process is more regulated at 
the FDA level, as opposed to its counterpart—state pharmacy boards.  The ODRC 
should only purchase drugs for lethal injections from compounding pharmacies that 
voluntarily choose to register with the FDA as an outsourcing facility.  
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